RussianPatents.com

Method of differentiating bacillus anthracis from other closely related species of genus bacillus based on determining differences in structure of chromosomal genes. RU patent 2514663.

Method of differentiating bacillus anthracis from other closely related species of genus bacillus based on determining differences in structure of chromosomal genes. RU patent 2514663.
IPC classes for russian patent Method of differentiating bacillus anthracis from other closely related species of genus bacillus based on determining differences in structure of chromosomal genes. RU patent 2514663. (RU 2514663):

C12R1/07 - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C-C12Q; OR C12S, RELATING TO MICRO-ORGANISMS
C12Q1/68 - involving nucleic acids
C12Q1/04 - Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
Another patents in same IPC classes:
Strain of filamentous fungus aspergillus oryzae - producer of maltogenic alpha-amylase / 2514224
Strain of fungus Aspergillus oryzae Amy T-52-3-21 produces maltogenic α-amylase, and it is deposited in the All-Russian Collection of Microorganisms Institute of Biochemistry and Physiology of Microorganisms n.a. GK Scriabin RAS under the number F-4476D. The strain is made on the basis of strain Aspergillus oryzae of All-Russian Collection of Microorganisms F-3927D using the genetic engineering methods. Activity of α-amylase at 120 h of growth of the strain is 600-640 units/ml.
Strain of bacteria bacillus vallismortis - destructor of oil and oil products / 2513702
Strain of bacteria Bacillus vallismortis VKPM V-11017 is proposed - destructor of oil and oil products. Strain may within short period of time in the wide range of temperatures from +8 to +37°C degrade oil by 78.3%.
Method to clean permafrost soils and water environment by spore-forming bacteria bacillus atrophaeus vkpm v-10592 / 2513699
Strain of bacteria Bacillus atrophaeus VKPM V-10592 is grown, and suspension is prepared from it, which is introduced into permafrost soil and water environment. Maintained at the specified parameters from 7 to 60 days, and then they determine quantity content of oil and oil products in permafrost soil and water environment.
Method of obtaining androst-4,9(11)-dien-3,17-dione from phytosterol Method of obtaining androst-4,9(11)-dien-3,17-dione from phytosterol / 2512076
Invention relates to biotechnology. Claimed is method of obtaining androst-4,9(11)-dien-3,17-dione from phytosterol. Microbiological oxidative elimination of side chain at atom C17 with formation of 9α-hydroxyandrost-4-en-3,17-dione is performed. Biomass is separated. 9α-hydroxyandrost-4-en-3,17-dione is extracted from clarified cultural liquid with aprotic organic solvent, selected from aromatic hydrocarbons or organochlorine hydrocarbons. After that, reaction of 9α-hydroxygroup of 9α- hydroxyandrost-4-en-3,17-dione dehydration is carried out in obtained extract. As dehydration agent applied is mineral acid, which contains water and is selected from group, which includes orthophosphoric, pyrophosphoric and chloric acids. Mineral acid is applied in quantity from 1 to 10 mol per 1 mol of 9α- hydroxyandrost-4-en-3,17-dione. In the process of dehydration reaction removal of excessive water is carried out either in presence of effective quantity of pyrophosphoric acid or by azeotropic distillation.
Differential diagnostic nutrient medium for identification of yersinia bacterium Differential diagnostic nutrient medium for identification of yersinia bacterium / 2511436
Invention refers to biotechnology, microbiology, and concerns the recovery and identification of pseudotuberculosis and intestinal yersiniosis agents (Y. Pseudotuberculosis and Y. Enterocolytica). A nutrient medium contains microbiological agar (dry), lactose, glucose, urea, calcium chloride, 1% alcoholic phenol red, 1% alcoholic methylene blue and distilled water in specific proportions.
Strain fusarium sambucinum - producent of fungal protein biomass / 2511427
Invention relates to biotechnology. Claimed is strain of Fusarium sambucinum, deposited in VKPM collection under number F-1161. Claimed strain is producent of protein food biomass.
Method of obtaining fungal protein biomass / 2511041
Invention relates to biotechnology. Claimed is method of obtaining food fungal biomass with high protein content. Multicycle deep cultivation of Fusarium sambucinum All-Russian collection of industrial microorganisms F-1161 on liquid nutritional medium, containing sources of carbon, nitrogen, mineral salts, separation and drying of wet fungus biomass are carried out. Cultivation is performed at pH from 3.5 to 7.0 under conditions of air aeration from 0.5 to 2.0 l/l/min. Temperature mode in each cycle of fermentation is supported from the beginning of the cycle to the point of switch at the level from 26 to 30°C, and further to the end of the cycle at the level from 22 to 25°C. Point of switch is determined by accumulation of biomass to concentration from 45 to 60% from maximally achievable in fermentation apparatus, or point of switch is determined by concentration of dissolved oxygen by its reduction to the value from 20 to 40% of saturation ( calculated per atmospheric air pressure).
Method of accelerated growth of staphylococcus aureus for diagnostics of infections associated with delivery of health care Method of accelerated growth of staphylococcus aureus for diagnostics of infections associated with delivery of health care / 2511031
Growing of Staphylococcus aureus is carried out in a nutrient medium containing yolk-salt agar. At a stage of preparation for analysis the growth stimulators of Staphylococcus aureus are introduced into the nutrient medium in the form of aqueous solutions at concentrations of 10-4-10-6 wt %. The following compounds are used as growth stimulators: tris(2-hydroxyethyl)ammonium 4-chlorophenyl-sulfanylacetate or tris(2-hydroxyethyl)ammonium 2-chlorophenyloxyacetate or tris(2-hydroxyethyl)ammonium 2-methyl-4-chlorophenyloxyacetate or tris(2-hydroxyethyl)ammonium 1-benzylindol-3-yl-sulfanylacetate.
Recombinant strain of escherichia coli tg1(prvmoscow3253g-l) for obtaining set of pcr-standards and set of pcr-standards for determination of concentration of rabies virus Recombinant strain of escherichia coli tg1(prvmoscow3253g-l) for obtaining set of pcr-standards and set of pcr-standards for determination of concentration of rabies virus "moskva 3253" in rabies antigen / 2511029
Invention relates to biotechnology and deals with recombinant strain of E. coli TG1(pRVMoscow3253G-L) for obtaining PCR-standards for quantitative determination of cDNA of rabies virus of strain "Moskva 3253".Recombinant strain is created on the basis of strain of E. coli TG1 by transformation with plasmid pRVMoscow3253G-L. Plasmid is obtained by ligation of fragment G-L of the region of genome of fixed rabies virus of strain "Moskva 3253", which has sequence SEQ ID NO1, into plasmid pGem-T. Also claimed is set of PCR-standards for quantitative determination of cDNA of rabies virus of strain "Moskva 3253" in rabies antigen. Set contains solutions of plasmid pRVMoscow3253G-L DNA in concentrations 108, 107, 105, 103 GE/ml. Concentration is determined by method of polymerase chain reaction, with hybridisation-fluorescence account of results.
Method of determining hexoses in supramolecular structures of cells in escherichia coli Method of determining hexoses in supramolecular structures of cells in escherichia coli / 2510846
Invention relates to biochemistry and molecular biology. Conservation of cells of Escherichia coli in presence of buffered 80-90% glycerol is performed. Cell envelopes are removed with 3% triton X-100. Cell supramolecular structures are successively extracted with increasing concentrations of salts: 0.14 M (bacterioplasm), 0.35 M (loosely linked with cell residue), 2 M NaCl (strongly linked with cell residue), and 6 M guanidine hydrochloride with 0.1% β-mercaptoethanol (cell residue). Acid hydrolysis is carried out in said fractions. Anthrone method is carried out, with preliminary purification of anthrone preparation. Calibration graph is built and quantity of hexoses is determined by means of calculation formula.
Method for measuring biological rhythm Method for measuring biological rhythm / 2512069
Invention refers to chronobiology. A method for measuring a circadian cycle on the basis of time-series data by expression levels obtained by measuring the expression levels of two clock-genes in biological samples taken from a subject three times a day. The clock-genes have different phases of the circadian measuring cycle of the expression level.
Method of quantitative determination of fixed rabies virus Method of quantitative determination of fixed rabies virus "moskva 3253" / 2511440
Invention relates to field of biotechnology and deals with method of quantitative determination of fixed rabies virus strain "Moskva 3253". Method includes decontamination and separation of RNA from virus-containing material, carrying out reaction of reverse transcription and polymerase chain reaction with hybridization-fluorescence account of results in "real time" mode with application of specific primers RV5-5'-GTTGGGCACTGAAACTGCTA-3', RV6-5'-GAATCTCCGGGTTCAAGAGT-3' and probe RV7-5'-ROX-AATCCTCCTTGAACTCCATGCGACAGA-BHQ2. Quantitative assessment of virus is determined on the basis of registration of signal of analysed sample fluorescence and its comparison with signal of fluorescence of PCR-standards, which contain different quantities of DNA-targets. Claimed method makes it possible to determine quantitative content of virus in rabies antigen of organ-tissue and culture origin.
Method for analysing disorders related to ovarian carcinoma Method for analysing disorders related to ovarian carcinoma / 2511408
Invention refers to genetic engineering, more specifically to analysing the disorders related to ovarian carcinoma, and may be used in medicine. The method involves determining the methylation status of CpG-dinucleotide in the genome in each sequence of a group of sequences SEQ ID NO:1-10 using a set of probes specific for the above sequences and able to be hybridised with the sequence along the full length. The above sequences are used as a part of a chip for detection, diagnosis and monitoring of the proliferative disorders related to ovarian cell proliferation, as well as for detection of a predisposition to the proliferative disorders, or treatment of the proliferative ovarian disorders.
Method and device for prediction of pharmaceutical effectiveness of drug preparation of humanised tnfα antibodies for treating rheumatoid arthritis Method and device for prediction of pharmaceutical effectiveness of drug preparation of humanised tnfα antibodies for treating rheumatoid arthritis / 2511394
Invention refers to molecular biology and pharmacology. What is presented is a method for the prediction of the pharmaceutical effectiveness of adalimumab for treating rheumatoid arthritis, wherein the method involves measuring a level of at least one of ADAMTS4 iRNA and ADAMTS5 iRNA in a sample taken from a subject, and determining if adalimumab is effective for rheumatoid arthritis in a subject on the basis of a level of at least one of ADAMTS4 iRNA and ADAMTS5 iRNA considered as a value.
Set of oligodeoxyribonucleotide primers and fluorescently labelled probe for identification of dna of adenoviruses of serotypes 3, 4, 7, 14, 21 by method of hybridisation-fluorescence polymerase chain reaction Set of oligodeoxyribonucleotide primers and fluorescently labelled probe for identification of dna of adenoviruses of serotypes 3, 4, 7, 14, 21 by method of hybridisation-fluorescence polymerase chain reaction / 2511043
Invention relates to field of biotechnology and deals with set, which includes oligodeoxyribonucleotide primers and fluorescently labelled probe for identification of DNA of adenovirus of serotypes 3, 4, 7, 14, 21 by method of hybridization-fluorescence polymerase chain reaction in real time mode. Claimed primers and probe have the following structure: external primer 5'→3' 5'-AATGTARTTGGGTCTGTTRGGCAT-3' internal primers 5'→3' 5'-CCCWTCGATGMTGCCCC-3' 5'-TCMACGGGYACRAAGCGCA-3' probe 5'→3' ROX-CCTGTCCGGCGATGTGCAT-BHQ2.
Recombinant strain of escherichia coli tg1(prvmoscow3253g-l) for obtaining set of pcr-standards and set of pcr-standards for determination of concentration of rabies virus Recombinant strain of escherichia coli tg1(prvmoscow3253g-l) for obtaining set of pcr-standards and set of pcr-standards for determination of concentration of rabies virus "moskva 3253" in rabies antigen / 2511029
Invention relates to biotechnology and deals with recombinant strain of E. coli TG1(pRVMoscow3253G-L) for obtaining PCR-standards for quantitative determination of cDNA of rabies virus of strain "Moskva 3253".Recombinant strain is created on the basis of strain of E. coli TG1 by transformation with plasmid pRVMoscow3253G-L. Plasmid is obtained by ligation of fragment G-L of the region of genome of fixed rabies virus of strain "Moskva 3253", which has sequence SEQ ID NO1, into plasmid pGem-T. Also claimed is set of PCR-standards for quantitative determination of cDNA of rabies virus of strain "Moskva 3253" in rabies antigen. Set contains solutions of plasmid pRVMoscow3253G-L DNA in concentrations 108, 107, 105, 103 GE/ml. Concentration is determined by method of polymerase chain reaction, with hybridisation-fluorescence account of results.
Set of synthetic oligonucleotides for identification of dna of parodontopathogenic microorganism treponema denticola by method of polymerase chain reaction / 2510857
Invention relates to field of biochemistry, in particular to set of synthetic oligonucleotides for identification of DNA of parodontopathogenic microorganism Treponema denticola by method of polymerase chain reaction. Claimed set includes specific to fragment of gene licCA of microorganism Treponema denticola primers 5'-TAG CCG GAA AAA CGA AGG AGT G-3' and 5'-CCC TGC TTG TTT GCA AAC ATA G-3', as well as probe (BHQ1)-5'-AAC CCA GCC G(FdT)T TCG TCC TCC GAC-3'-P, where BHQ1 stands for attached to 5'-tail nucleotide blank fluorescence damper, FdT - fluorescent dye FAM, attached to T nucleotide.
Set of synthetic oligonucleotides for identification of dna of parodontopathogenic microorganism candida albicans by method of polymerase chain reaction / 2510856
Invention relates to field of biochemistry, in particular to set of synthetic oligonucleotides for identification of DNA of parodontopathogenic microorganism Candida albicans by method of polymerase chain reaction. Claimed set includes specific to fragment of gene gr1 of microorganism Candida albicans primers 5′-TTGCCATTCTTGGACGAAGG-3′ and 5′-CAACAATGGCAACTTTTTTAGG-3′, as well as probe (BHQ1)-5′-TCCTCCTTCAG(FdT)CCCTGGTGCTGA-3′-P, where BHQ1 stands for attached to 5'-tail nucleotide blank fluorescence damper, FdT - fluorescent dye FAM, attached to T nucleotide.
Diagnostic technique for vaginitis in pregnant women by interleukine gene irna expression in vaginal smears Diagnostic technique for vaginitis in pregnant women by interleukine gene irna expression in vaginal smears / 2510855
Invention refers biotechnology and medicine. What is presented is a method based on measuring interleukin IL1B, IL8, IL10 and IL18 gene iRNA expression in vaginal smears in relation to the presence of iRNA of the reference genes B2M, GUS, TBP or HPRT; the derived expressions are used to calculate canonical linear discriminant function (CLDF) as follows: Y=1.09*IL1B-0.61*IL8+0.21*IL10-0.11*IL18-0.91 (formula 1), wherein IL1B is relative IL1B expression, IL8 is relative IL8 expression, IL10 is relative IL10 expression, IL18 is relative IL18 expression; IL=2^(Cpmin-Cpil)/NF (formula) wherein IL is relative interleukin gene expression, Cpmin is a coefficient of minimum expression, for IL1B Cpmin=17.9; IL8 Cpmin=16.6; IL10 Cpmin=28.8; IL18 Cpmin=23.3; Cpil is a threshold cycle of related IL in a sample determined automatically; NF is a rate setting factor calculated by formula 3: NF = 4 NFgus*NFhprt*NFb2m*NFtbp (formula 3) wherein NF is a rate setting factor calculated as a geometrical mean of 4 rate setting factors for reference genes (see formula 4); NFref=2^(Cpmin-Cpref) (formula 4), wherein NFref is a rate setting factor for the reference gene, Cpmin is a coefficient for minimum expression of the reference gene, Cpref is the threshold readings in the sample; Cpmin for the reference genes are as follows: GUS Cpmin=26.5; HPRT Cpmin=26.8; B2M Cpmin=18.9; TBP Cpmin=28.4; if CLDF≤0.1, the absence of vaginitis is stated; CLDF>0.1 stands for vaginistis.
Test-system for identification of rna virus of bluetongue by rt-pcr method in real time mode / 2510851
Invention relates to field of biotechnology. Claimed test-system for identification of RNA virus of bluetongue includes serogroupspecific primers and DNA-probe, complementary sites of conservative 10-th segment, which have the following nucleotide composition (5' - 3'): BTV/10/qf - ACKggTgCWACgCAAACACA; BTV/10/z - FAM - AARgCTgCATTCgCATCgTACGC - BHQ1; BTV/10/qr - ACRTCATCACgAAACgCTTC.
Differential diagnostic nutrient medium for identification of yersinia bacterium Differential diagnostic nutrient medium for identification of yersinia bacterium / 2511436
Invention refers to biotechnology, microbiology, and concerns the recovery and identification of pseudotuberculosis and intestinal yersiniosis agents (Y. Pseudotuberculosis and Y. Enterocolytica). A nutrient medium contains microbiological agar (dry), lactose, glucose, urea, calcium chloride, 1% alcoholic phenol red, 1% alcoholic methylene blue and distilled water in specific proportions.

FIELD: biotechnology.

SUBSTANCE: method includes sample preparation, DNA isolation, PCR statement. At that in carrying out PCR, the oligonucleotide primers are used, which are complementary to sequences of the chromosomal genes fliC and hom2, having the following sequences: fliC-F: 5'-TGGAGCAGTAACAATTGG-3', fliC-R: 5'-GCACCACTGATAGAAATGTTAG-3', hom2-F: 5'-GACGTGTTAAAAGAAGCCCA-3', hom2-R: 5'-CACCAATTTCGTCTTTTACA-3', followed by electrophoretic analysis of the amplification products, when the formation of the amplification product is 153 bps in size it is indicative of belonging of the strain under study to the species B.anthracis, formation of the amplification product with size of 550 bps is indicative of belonging of the strain under study to the other species of the genus Bacillus.

EFFECT: invention enables to differentiate effectively the bacillus anthracis from other species of bacilli.

1 dwg, 1 ex

 

The invention relates to the field of molecular Microbiology, in particular to the diagnosis of anthrax germs. The proposed invention allows to quickly and effectively identify DNA Bacillus anthracis in biological material and the environment when conducting diagnostic studies in practical health care and veterinary and implement a reliable differentiation from other bacillary species.

The causative agent of anthrax - gram-positive spore-forming organism belonging to the genus Bacillus. In most close phylogenetic relationship with Century anthracis are the types of B. cereus, B. thuringiensis, B. mycoides, Century pseudomycoides Century and weihenstephanensis. The similarity of the genetic, morphological and physiological characteristics allows to allocate them in a particular taxonomic group, the so-called "1-St group bacilli".

The classical scheme of research material on the presence of anthrax based on the definition of the phenotypic characteristics - colony morphology, sensitivity to penicillin in the test "pearl necklace", sensitivity to diagnostic bacteriophages, ability to formation of L-glutamine capsules for special environments, lack of hemolysis on agar with defibrinirovannaya the blood of sheep, lack of mobility and alkaline phosphatase activity. However, quite often isolated strains Century anthracis, which on one or more characteristics different from the typical characteristics.

The known method of differentiation strains of Bacillus anthracis in virulence in vitro carried out on a special nutrient medium for testing education capsules and anthrax toxin in the atmosphere FROM 2 [1]. The known method of identification Century anthracis with differentiation strains on production of capsules, Pro-tektivnye antigen or antigens S-layer consisting in sowing culture of strain on a special testing environment for education capsules in the atmosphere FROM the 2nd and subsequent formulation of reaction immunodiffusion using serums to the protective antigen and protein S-layer Bacillus anthracis [2]. However, these methods are designed to work with a pure culture Century anthracis, they cannot be used to detection of anthrax germs in biological material and environmental objects and differentiation from other representatives of the genus Bacillus.

Modern development of genetics and molecular Microbiology allows the diagnostics of pathogenic bacteria based amplification and sequencing technologies. Molecular-genetic differentiation has a high resolution and excludes various interpretations associated with phenotypic variability of bacteria. In the genome anthrax, in addition chromosomes, there are two plasmids - pXO1 and pXO2. Plasmid genes determine a synthesis of the main determinants of pathogenicity Bacillus anthracis. The presence of plasmids pXO1 and pXO2 a differential diagnostic feature that distinguishes a Century anthracis from other representatives of the genus Bacillus. Practically all domestic and foreign PCR display system anthrax based on detection of sequences plasmid genes.

There is a method of identifying anthrax using a commercial kit Gensis - "Test-system for detection of DNA Century anthracis Rho+by polymerase chain reaction" (FCUS antiplague research Institute "Microbe", Saratov) [3]. The set contains the primers complementary to the movie sequences of the gene pagA, located on a plasmid pXOl. However, this test system will not detect mikoplazmenne strains Century anthracis, containing only plasmid pXO2, or besplatnye derivatives. In addition, it is impossible to distinguish vaccine strains Century anthracis from virulent.

There is a method of identifying anthrax using a commercial kit "AmpliSens ® Century anthracis - FRT: reagent kit for detection of DNA vegetative forms and spores of Bacillus anthracis in biological materials and environmental objects by the method of polymerase chain reaction (PCR) with hybridization-fluorescent detection in "real time" (fsri Central research Institute of epidemiology, Moscow) [4]. The test system is based on the identification of the fragment pagA gene is localized in the composition of plasmids pXO1, and Sarah a gene located on a plasmid pXO2. However, it does not define the strains of Bacillus anthracis, deprived of plasmids. Bacterial plasmids less stable genetic elements than chromosomal DNA, and with different frequency to eliminiruyutza. On the other hand, plasmids, identical pXO1 and pXO2, found in the separate strains closely related Century anthracis bacillary species [5, 6, 7]. Some of these unusual strains isolated from humans or animals with symptoms resembling anthrax.

Greater specificity have a test system with primers on fragments of chromosomal genes. However, the search for species-specific chromosomal loci hampered by high homology chromosomal DNA anthrax and individual members of a species B. cereus [8].

Known methods of detection Century anthracis and intraspecific differentiation by plasmid composition, based on the integrated use of primers for gene fragments pag, cya, lef, located on a plasmid pXO1, cap gene, located on a plasmid pXO2, and chromosomal sequence VA [9, 10]. However, the uniqueness of the marker VA for anthrax questioned after the discovery of individual strains of B. cereus and B. thuringiensis containing a sequence We identical with anthrax [11].

The known method of identification and differentiation Century anthracis using multiplex amplification test systems, including primers on fragments of plasmid genes of Mas and SARS, as well as chromosomal gene sap encoding protein S-layer [12]. However, according to genome-wide sequences presented in the databases of the National Center for Biotechnology Information (NCBI), the nucleotide sequence of the gene sap in strains Century anthracis and certain other species of the genus Bacillus identical.

Y. Qi et al., comparing chromosomal sequences smear-positive strains found in Bacillus anthracis synonymous substitution of one nucleotide in the rpoB gene encoding β-subunit of RNA polymerase [13]. Perspectivity of use of this marker for the implementation of differentiation Century anthracis among phylogenetically close species of the genus Bacillus. But later when testing 319 smear-positive strains identified a strain of B. cereus with the rpoB gene sequence identical to a similar sequence in B. anthracis [14].

Agaisse N. et al. in the process of comparative analysis of sequenced genomes Century anthracis and B. cereus revealed polymorphism of single nucleotide in chromosomal gene pleiotropic regulator plcR [15]. Transcriptional regulator plcR responsible for various cell functions related to the pathogenicity of the organism and survival in a hostile environment. Nonsense mutation in the gene plcR used when typing of strains Century anthracis different origin and refers to the canonical SNP (single nucleotide polymorphism) [16]. Hurtle W. et al. revealed a single synonymous nucleotide substitution in chromosomal gyrA gene strains Century anthracis to differentiate them from representatives of other bacillary types [17]. On the basis of gyrA gene polymorphism was created probe with fluorescent label. However, to detect genetic changes in the form of single nucleotide substitutions requires special equipment for PCR in real time or sequencing. In addition, mutations in the form of single nucleotide substitutions subject reverse reverse.

Irenge L. et al. was offered a two-stage real-time PCR for the diagnosis of anthrax infection [18]. At the first stage of screening strains Century anthracis using plasmid genes of Bacillus anthracis, the second stage consists of more specific identification of strains Century anthracis with the use of chromosomal target genes And pur and ptsI. However, the diagnostic study carried out in two stages, with more time and less economical.

Wielinga P. et al. developed multiloci real-time PCR for the simultaneous detection of chromosomal and plasmid loci of anthrax germs. As chromosome marker selected lambda Profi 3 type that is part of a conservative region of DNA Century anthracis [19]. However, it is not excluded the probability of recombination events in the genome Century anthracis, leading to the elimination of propaga.

In 2011 Ahmod N. et al. find a deletion 72 P.N. in a conservative region of a chromosome anthrax, encoding ATP synthase gene weas [20]. Testing with specific primers 174 smear-positive strains, including 39 strains of anthrax, showed the presence of mutations in the vast majority of strains Century anthracis, except Century anthracis A. Chromosome marker UAAS was recommended for differentiation Bacillus anthracis from smear-positive strains of other types of PCR and persecutione. However, the use of chromosome mutations in the form deletions part of nucleotides in any gene does not allow to detect the microorganism. For simultaneous indication of bacterial pathogen and its differentiation from closely related species optimal use of several species-specific loci.

The objective of the invention is development of a method that allows detection of the causative agent of anthrax while conducting diagnostic studies and conduct differentiation from other representatives of the genus Bacillus.

The technical result consists in the efficient display Bacillus anthracis and improving the reliability of its differentiation from strains phylogenetically close species.

The technical result is achieved indication anthrax by polymerase chain reaction primers on chromosomal genes, which provides for sample preparation, DNA detection, staging PCR using synthetic oligonucleotide primers complementary sequences of chromosomal genes fliC and hom2.

Primers on these genes have the following sequence:

fliC-F: 5'-TGGAGCAGTAACAATTGG-3',

fliC-R: 5*-GCACCACTGATAGAAATGTTAG-3',

hom2-F: 5'-GACGTGTTAAAAGAAGCCCA-3',

hom2-R: 5'-CACCAATTTCGTCTTTTACA-3*.

The proposed method is based on the use of DNA targets fragments of chromosomal genes fliC and hom2. Earlier in the process of comparative analysis of nucleotide sequences of genes life support smear-positive strains we have identified specific to anthrax chromosomal mutations. One of the highly specific sites had been found in the gene fliC determining the synthesis of flagellin - the main component of the bacterial flagellum. In position 383 P.N. from the beginning of the gene fliC in strains Century anthracis is present insert 231 nucleotide, leading to the termination of the synthesis of flagellin. When setting PCR with primers complementary to the movie sequences insertion, education product amplification occurs in the interaction with DNA Century anthracis.

Additional DNA target for diagnostic studies serves as we found a mutation in the gene hom2, encoding the enzyme gomoserinlaktonazy. Deletion 42 nucleotides in the positions form 1042 by P.N. 1083 P.N. from the beginning of the gene hom2 blocks the synthesis of L-homoserine, from which a series of consecutive reactions are formed methionine, threonine and cysteine. Given the relatively small extent of the defect DNA primers for gene hom2 selected so that the sequence of one of them had directly on the area of the deletions. In this case, the education of product amplification is registered only in reactions with DNA strains bacillary species other than Century anthracis. Use extra chromosomal locus increases the reliability of differentiation anthrax from strains phylogenetically close species. A mutation in a gene hom2 apparently occurred at the initial stage of branches from common predecessor and the formation of a Century anthracis as a separate species. In this case it is species-specific genetic marker.

The possibilities of the proposed method, introduce a plasmid token that allows simultaneous detection of the anthrax microbe to determine the facilities to isolate virulent vaccine or atypical strains. Calculation of primers and selection conditions polymerase chain reaction conducted with a view to future use in one of the reaction mixture primers on the fragments of chromosomal genes fliC, hom2 and plasmid determinants pagA, cap And [19]. The size of the generated in multiloci PCR amplification products to separate them from each other in an electrophoretic separation in agarose gel. Staging a one-step PCR economically it is more efficient and requires less time to study.

The method is as follows:

DNA isolation from material previously decontaminated according to the standard procedure is carried out in accordance with MU 1.3. 2569-09 "Organization of work of laboratories, using the methods of amplification of nucleic acids when working with material containing microorganisms 1 - IV groups of pathogenicity (M, 2009).

Polymerase chain reaction carry out according to standard method (MU 1.3. 2569-09) applying the above mentioned primers on genes hom2 and fliC.

Oligonucleotide primers used for PCR amplification of the gene fragments hom2 and fliC, calculated on the basis of the nucleotide sequences of these genes have smear-positive strains presented in NCBI databases: B. anthracis Ames, Ames 0581, Steme, CDC 684, A0248; B. cereus ATCC14579, ATCC10987, ZK, AH187, B4264, AH820, G9842, Q1, 03BB102; Bacillus thuringiensis 97-27, Al Hakam, BMB171; B. weihenstephanensis KBAB4_4052, B. licheniformis ATCC 14580, DSM13; B. B. megaterium QM B1551, DSM 319; B. subtilis subsp.spizizenii, BSU35150, BSn5. Primers analyzed using computer programs BLAST on the web server NCBI (http://www.ncbi.nlm.nih.gov/BLAST/) to confirm their specificity and the absence of homology with nucleotide sequences of smear-positive strains of the species present in databases (GenBank, EMBL, DDBJ).

Using calculated primers spend PCR amplification of the gene fragments hom2 and JliC determine the existence and the dimensions of the resulting amplicons. Primers on genes hom2 and fliC have the following sequence:

fliC-F: 5'-TGGAGCAGTAACAATTGG-3',

fliC-R: 5'-GCACCACTGATAGAAATGTTAG-3',

hom2-F: 5'-GACGTGTTAAAAGAAGCCCA-3',

hom2-R: 5'-CACCAATTTCGTCTTTTACA-3'.

Polymerase chain reaction amplification of the gene fragments hom2 and fliC perform the following program: one cycle 94 OC for 5 min, 30 cycles at 94 C is 30 sec, 58 degrees C - 30 s, 72 C is 30 seconds and the final cycle - 3 min at 72 C. Electrophoretic analysis of PCR products is carried out by the method of electrophoresis in 2% agarose gel relatively standard markers molecular masses with the size from 100 to 3000 gel

For strains of Bacillus anthracis, the PCR product corresponds to the size of 153 gel, for smear-positive strains of other species - 550 P.N.

Thus, the developed method will allow you to detect anthrax, as well as to conduct its reliable differentiation from other representatives of the genus Bacillus.

The invention is illustrated by example.

Example. The study material containing culture strain Century anthracis or strain another bacillary form (Modelling experiment).

Disinfection of samples tested carried out according to the Methodological instructions MU 3.5.5.1034-01 "Disinfection of the investigated material infected with bacteria of I-IV groups of pathogenicity, working by PCR".

DNA isolation is performed with the help of a Set of reagents for sample preparation (DNA)" produced FKUS antiplague research Institute "Microbe".

The reaction mixture for the production of PCR reactions prepare for the recipe:

water deionized - 12,5 MKL

the solution dNTP (2.5 mm) - 2 MKL

primer fliC-F (12 gr/ ml) - 0,5 MKL

primer fliC-R (12 gr/ ml) - 0,5 MKL

primer hom2-F (12 gr/ ml) - 0,5 MKL

primer hom2-R (12 gr/ ml) - 0,5 MKL

the reaction buffer NPF (x 10) - 2,5 MKL

MgCl 2 0.25 M - 0,8 MKL

the enzyme Taq polymerase (5 units/ ml) - 0.2 to MKL

the sample DNA - 5 mm.

The total volume of the reaction mixture is 25 MKL 1 the sample.

Amplification of the gene fragments fliC and hom2 in PCR performed according to the scheme: denaturation - 94 OC for 5 min, 30 cycles at 94 C is 30 sec, the annealed primers - 58 degrees C - 30 sec, elongation of the chain 72 C is 30 seconds and the final cycle - 3 min at 72°N Electrophoretic analysis of PCR products carry a 2% agarose gel.

In all samples containing DNA Century anthracis, synthesized product amplification size 153 P.N. that defines the insertion of a gene fliC. When DNA testing of representatives of various bacillary species register the product amplification a 550 P.N. detecting unmodified gene sequence hom2. Due to the deletion of part of the nucleotide sequences of the gene hom2 in strains of anthrax amplification with calculated primers on its part in these samples is not happening (the drawing). The drawing shows the results of PCR-analysis with primers for gene fragments fliC and hom2 strains Century anthracis and other bacillary forms: 1. Century anthracis Pasteur; 2. Century anthracis 55; 3. Century anthracis Ihtiman; 4. Century anthracis KM (7); 5. Century anthracis KM (8); 6. Century anthracis Sterne 34F2; 7. Century anthracis STI-1; 8. Century anthracis KM; 9. Century anthracis 29; 10. Century anthracis 91 KM; 11. a token of molecular masses "On' GeneRuler™ 100bp DNA Ladder Plus redy-to-use" (Fermentas) (3000, 2000, 1500, 1200, 1000, 900, 800, 700, 600, 500,400, 300, 200, 100 P.N.); 12. Century thuringiensis HD-1; 13. B. thuringiensis 2090; 14. B. thuringiensis 69/6; 15. B. cereus 569; 16. B. cereus 108; 17. B. cereus 8; 18. B. pseudoanthracis 104.

Sensitivity amplification reaction with primers fliC-F, fliC-R, hom2-F and hom2-R was estimated in the study of samples of DNA extracted from a ten-fold dilutions of pure cultures of anthrax Century anthracis, and amounted to 1 x 10 2 -1 x 10 4 spores/ml

Literature

1. Eremenko E.I., Buravtseva I.E., Funtikova T.N. Method of differentiation strains of Bacillus anthracis in virulence in vitro // Patent RF №2101351 (C12N 1/20, C12Q 1/04, C12N 1/20, C12R 1:07) - published 10.01.1998,

2. Barkov I.A., Barkov A.M., V.V. Alekseev, ALEXANDER Lipnitsky Method of identification of Bacillus anthracis with differentiation strains for the production of capsules, protective antigen and antigens S-layer // Patent RF №2376385 (C12Q 1/04, C12R 1/07, G01N 33/559) - published, 20.12.2009

3. Tuchkov I.V. Design and implementation in practice of genetic diagnostic test-systems for detection of DNA anthrax // Avtoref. dis ... Cand. the honey. of Sciences. - Saratov, 2005. - 19 C.

4. Abdrashitova A.S., Sabina L.V., Malakhaeva A.N., Aspen N.A. research on the efficiency of the reagent kit for detection of DNA vozbuditelei anthrax, Brucellosis and cholera PCR in "real time" // Modern technologies in improvement of prevention and response to emergencies in public health sanitary-epidemiological character (XI Materials International scientific-practical conference). Saratov. - 2012. - S-15.

5. Avashia S., Riggins W., Lindley, Hoffmaster A., Drumgoole R., Nekomoto,T. And P. Jackson, K. Hill, K. Williams, L. Lehman, Libal M., P. Wilkins, Alexander J., Tvaryanas A., Betz T. Fatal pneumonia among metalworkers due to inhalation exposure to Bacillus cereus containing Bacillus anthracis toxin genes // Clin. Infect. Dis. - 2007. - V.44. - P.414-416.

6. Hoffmaster A., Ravel J., Rasko D., G. Chapman, M. Chute, Marston C, De Century, Sacchi C, Fitzgerald C, L. Mayer, M. Maiden, Priest F., Barker m., L. Jiang, Cer R., Rilstone J. S. Peterson, Weyant R., D. Galloway, Read, So, Popovic So, Fraser C. Identification of anthraxtoxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax // Proc. Natl. Acad. Sci. USA - 2004. - V.101. - P.8449-8454.

7. Klee S., Ozel M., Appel Century, Boesch C, Ellerbrok, H., Jacob D., G. Holland, Leendertz F., Pauli g, Grunow R., Nattermann H. Characterization of Bacillus anthracis-\\k& bacteria isolated from wild great apes from Cote dTvoire and Cameroon // J. Bacteriol. - 2006. -V.188.-P.5333-5344.

8. Tourasse N., Helgason E., Okstad O., Hegna I., Kolsto A. The Bacillus cereus group: novel aspects of population structure and genome dynamics // J. Appl. Environ. - 2006. -V.101.-P.579-593.

9. Patra G., Sylvestre P., Ramisse V., Therasse J., Guesdon J. Isolation of a specific chromosomic DNA sequence of Bacillus anthracis and its possible use in diagnosis // FEMS Immunol. Med. Environ. - 1996. - V.15. - P.223-231.

10. Ramisse V., Patra G., Garrigue H., Guesdon J. M. Mock Identification and characterization of Bacillus anthracis bymultiplex PCR analysis of sequences on plasmids pXOl and Rho and chromosomal DNA // FEMS Environ. Letters. - 1996. - V.145. - P.9-16.

11. Patra G., Vaissaire J. Weber-M. Levy, Le Doujet C, Mock M. Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997 // J. Clin. Environ. - 1998. - V.36. - P.3412-3414.

12. Tsygankova I., Eremenko H. R. Ryazanova A.G., E. Tsygankov Multiplex amplification test-system for identification and differentiation of Bacillus anthracis II, Ukr. microbiol. - 2005. - №3. - Pp.69-74.

13. Y. Qi, Patra G., X. Liang, L. Williams, S. Rose, Redkar R., DelVecchio V. Utilization of the rpoB gene as a specific chromosomal marker for real-time PCR detection of Bacillus anthracis II Appl. Environ. Environ. - 2001. - V.67(8). - P.3720-3727.

14. Zasada A., Gierczynski R., Raddadi N., Daffonchio D., M. Jagielski Some strains of Bacillus thuringiensis share rpoB nucleotide polymorphisms also present in Bacillus anthracis II J. Clin. Environ. - 2006. - V.44. - P.1606-1607.

15. Agaisse H., Gominet M., Okstad O., Kolstø A., Lereclus D. PlcR is a pleiotropic regulator of increasing interest among virulence factor gene expression in Bacillus thuringiensis // Environ Mol. - 1999. - V.32. - P.1043-1053.

16. Easterday R. Van Ert M., Simonson So, D. Wagner, Kenefic L., Allender C, Keim P. Use of single nucleotide polymorphisms in the plcR gene for specific identification of Bacillus anthracis II J. Clin. Environ. - 2005. - V.43 (4). - P.1995-1997.

17. Hurtle W., E. Bode, Kulesh D., R. Kaplan, J. Garrison, Bridge D., M. House, M. Frye, Loveless Century, Norwood D. Detection of the Bacillus anthracis gyrA gene by using a minor groove binder probe. J. Clin. Environ. - 2004. - V.42. - P.179-185.

18. Irenge L. J. Durant, Tomaso H., Pilo P. Olsen J., Ramisse V., Mahillon J., Gala J. Development and validation of a real-time quantitative PCR assay for rapid identification of Bacillus anthracis in environmental samples //Appl. Environ. Biotechnol. - 2010. - V.88.-P.1179-1192.

19. Wielinga P., Hamidjaja R., Agren J., Knutsson R., Segerman Century, Flicker M., Ehling-Schulz m, Groot A., Burton j, T. Brooks, Janse I., Rotterdam B. A multiplex real-time PCR for identifying and differentiating B. anthracis virulent types // International J. Food Environ. - 2011. - V. 145. - P. 137-144.

20. Ahmod N., R. Gupta, H. Shah Identification of a Bacillus anthracis specific indel in the yeaC gene and development of a rapid pyrosequencing assay for distinguishing B. anthracis from the B. cereus group // J. Environ. Methods. - 2011. - V. 87. - 278 P. - 285.

Method of differentiation anthrax from other closely related species of the genus Bacillus on the basis of differences in the structure of chromosomal genes, providing for sample preparation, DNA detection, staging PCR, wherein by PCR apply oligonucleotide primers complementary sequences of chromosomal genes fliC and hom2 with the following sequence: fliC-F: 5'-TGGAGCAGTAACAATTGG-3', fliC-R: 5'-GCACCACTGATAGAAATGTTAG-3', hom2-F: 5'-GACGTGTTAAAAGAAGCCCA-3', hom2-R: 5'-CACCAATTTCGTCTTTTACA-3' followed electrophoretic analysis of amplification products, in which the formation of product amplification size 153 P.N. shows toiletries investigated strain to mind Century anthracis, education product amplification of a 550-BP suggests the facilities studied the strain another species of the genus Bacillus.

 

© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.